v3.23.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2023
Dec. 31, 2022
Current Assets:    
Cash $ 2,008,606 $ 6,970,110
Prepaid expenses and other current assets 925,780 1,958,280
Total Current Assets 2,934,386 8,928,390
Intangible assets, net 1,669,328 1,658,858
In-process research and development 9,063,000 9,063,000
Total Assets 13,666,714 19,650,248
Current Liabilities:    
Accounts payable 836,990 1,801,210
Accounts payable – related parties 53,257
Accrued expenses 2,499,645 2,284,516
Accrued expenses - related parties 287,420 188,159
Loans payable - current portion 588,216 1,308,516
Derivative liabilities 7,641 75,381
Total Current Liabilities 4,273,169 5,657,782
Loans payable – noncurrent portion 26,314 31,189
Deferred tax liability 2,651,428 2,617,359
Total Liabilities 6,950,911 8,306,330
Commitments and contingencies (Note 8)
Stockholders’ Equity:    
Preferred stock, $0.0001 par value; 5,000,000 shares authorized; (see designations and shares authorized for Series A, Class C and Class K preferred stock)
Class C Preferred Stock; 1 share authorized, issued and outstanding at June 30, 2023 and December 31, 2022
Class K Preferred Stock; 1 share authorized, issued and outstanding at June 30, 2023 and December 31, 2022
Common stock, $0.0001 par value; 100,000,000 shares authorized; 5,317,586 and 3,746,906 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively 532 375
Additional paid-in capital 125,466,190 121,637,611
Accumulated other comprehensive income (2,900,127) (2,885,523)
Accumulated deficit (115,850,792) (107,408,545)
Total Stockholders’ Equity 6,715,803 11,343,918
Total Liabilities and Stockholders’ Equity $ 13,666,714 $ 19,650,248

Source

PDF HTML
ZIP XLS HTML